Chengda Pharmaceuticals

Chengda Pharmaceuticals is a China-based publicly listed pharmaceutical manufacturing company focused on CDMO services, pharmaceutical intermediates, active pharmaceutical ingredients, and L-carnitine series products. The company provides process development, pilot-scale production, commercial manufacturing, and registration support for multinational pharmaceutical companies and R&D institutions. Its product and service portfolio is centered on small-molecule intermediates and APIs spanning anti-cancer, antiviral, anti-infective, cardiovascular, and other therapeutic categories. In addition to CDMO activities, Chengda commercializes L-carnitine and related products for pharmaceutical, food, and feed applications and has registrations and exports across the United States, Europe, Japan, and other international markets. The company operates manufacturing facilities in Jiashan, Zhejiang, and has been listed on the Shenzhen Stock Exchange since 2022.